Published in Gene Therapy Weekly, June 19th, 1995
In addition, the muscle delivery system may serve as a suitable model for human gene therapy for hypertensive diseases, indicated William Xiong and colleagues, Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.
Xiong et al. demonstrated that direct delivery of the tissue kallikrein gene by a single muscle injection can cause a sustained reduction in blood pressure ("Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats," Hypertension, April...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.